Outsourcing to a contract development and manufacturing organization (CDMO) can be critical to success, especially for companies with limited resources. Despite an increasingly crowded field, selecting the right CDMO partner that caters to your specific needs is a complex decision.
CCRM provides innovative CDMO services to enable the development and commercialization of cell and gene therapies, and regenerative medicine-based technologies. We offer a customer-focused approach that’s tailored to each client. We solve the big challenges in cell and gene therapy through the seamless integration of four pillars: extensive expertise, enabling technologies, collaborative processes, and specialized infrastructure.
In this blog post, we’ll explore how these four pillars guide our work with our clients, with examples from two of our clients, Avectas and DiscGenics.